针对线粒体复合体进行癌症治疗
Alaa M A Osman1, Alya A Arabi1
1College of Medicine and Health Sciences, Department of Biochemistry and Molecular Biology, United Arab Emirates University, AlAin, P. O. Box: 15551, United Arab Emirates.
Biochemical pharmacology
|January 12, 2026
概括
针对线粒体电子运输链 (ETC) 综合体,通过破坏癌细胞能量生产,为癌症治疗提供了一种新的策略. 本综述探讨了ETC抑制,生物能干扰和先进的治疗方法,包括AI和纳米医学.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 线粒体电子运输链 (ETC) 综合体I-IV对癌细胞能量和生物合成至关重要.
- 抑制这些复合体是阻止癌细胞存活的有希望的策略.
研究的目的:
- 对癌症治疗中ETC复合抑制的当前发现进行审查.
- 探索生物能干扰和新的治疗策略,如光动力疗法 (PDT).
- 突出AI和纳米技术在开发ETC向癌症药物的作用.
主要方法:
- 对ETC复合抑制的in silico,in vitro和in vivo研究进行了审查.
- 对生物能破坏机制的分析.
- 探索治疗策略,包括PDT,小分子,重用药物,人工智能和纳米技术.
主要成果:
- 抑制ETC复合体有效地阻断了癌细胞的生存.
- 光动力疗法 (PDT) 和其他新的策略显示出有前途.
- 人工智能和纳米技术可以加速发现ETC向的抗癌药物.
- 准ETC复合体可以整合到精准医学中.
结论:
- 线粒体ETC复合体是开发新型抗癌药物的可行目标.
- 生物能量破坏,创新疗法和人工智能驱动的方法的结合可以增强癌症治疗.
- 精准医学策略可以利用ETC依赖性来进行个性化癌症治疗.
相关概念视频
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Mitochondrial Membranes
16.6K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.6K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K


